E-LIB Suche - Ergebnisse für: Amiri-Kordestani, Laleh

1

Cytoreductive nephrectomy in the era of immune checkpoint i..:

Fallah, Jaleh ; Gittleman, Haley ; Weinstock, Chana...
JNCI: Journal of the National Cancer Institute. , 2024

Link: https://doi.org/10.1093/..

2

A U.S. Food and Drug Administration–pooled Analysis of Fron..:

Lee, Daniel ; Gittleman, Haley ; Weinstock, Chana...
European Urology. 84 (2023) 4 - p. 373-378 , 2023

Link: https://doi.org/10.1016/..

3

To Adjudicate or Not Adjudicate:

Hicks, Karen A. ; Fashoyin-Aje, Lola A. ; Amiri-Kordestani, Laleh
JACC: CardioOncology. 4 (2022) 5 - p. 657-659 , 2022

Link: https://doi.org/10.1016/..

4

Arterial aneurysm and dissection with systemic vascular end..:

Cheng, Connie ; Nguyen, Michelle Nadeau ; Nayernama, Afrouz...
Vascular Medicine. 26 (2021) 5 - p. 526-534 , 2021

Link: https://doi.org/10.1177/..

5

Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: Fro..:

Chang, Elaine ; Pelosof, Lorraine ; Lemery, Steven...
The Oncologist. 26 (2021) 10 - p. e1786-e1799 , 2021

Link: https://doi.org/10.1002/..

6

Oncology approvals in 2020: a year of firsts in the midst o..:

Amiri-Kordestani, Laleh ; Pazdur, Richard
Nature Reviews Clinical Oncology. 18 (2021) 3 - p. 129-130 , 2021

Link: https://doi.org/10.1038/..

7

US Food and Drug Administration regulatory updates in neuro..:

Mehta, Gautam U. ; Barone, Amy K. ; Bradford, Diana...
Journal of Neuro-Oncology. 153 (2021) 3 - p. 375-381 , 2021

Link: https://doi.org/10.1007/..

8

FDA Approval Summary: Olaparib Monotherapy or in Combinatio..:

Arora, Shaily ; Balasubramaniam, Sanjeeve ; Zhang, Hui...
The Oncologist. 26 (2020) 1 - p. e164-e172 , 2020

Link: https://doi.org/10.1002/..

9

FDA Approval Summary: Rucaparib for the Treatment of Patien..:

Anscher, Mitchell S. ; Chang, Elaine ; Gao, Xin...
The Oncologist. 26 (2020) 2 - p. 139-146 , 2020

Link: https://doi.org/10.1002/..

10

Patient-Friendly Language to Facilitate Treatment Choice fo..:

Kim, Janice ; Gao, Jennifer ; Amiri-Kordestani, Laleh..
The Oncologist. 24 (2019) 8 - p. 1011-1012 , 2019

Link: https://doi.org/10.1634/..

11

Corrigendum to "Assessing cardiac safety in oncology drug d..:

Seltzer, Jonathan H. ; Gintant, Gary ; Amiri-Kordestani, Laleh...
American Heart Journal. 218 (2019) - p. 133 , 2019

Link: https://doi.org/10.1016/..

12

Assessing cardiac safety in oncology drug development:

Seltzer, Jonathan H ; Gintant, Gary ; Amiri-Kordestani, Laleh...
American Heart Journal. 214 (2019) - p. 125-133 , 2019

Link: https://doi.org/10.1016/..

13

Myocarditis Associated with Immune Checkpoint Inhibitors: A..:

Neilan, Tomas G. ; Rothenberg, Mace L. ; Amiri-Kordestani, Laleh...
The Oncologist. 23 (2018) 8 - p. 874-878 , 2018

Link: https://doi.org/10.1634/..

14

21st Century Cardio-Oncology:

Sheng, Calvin Chen ; Amiri-Kordestani, Laleh ; Palmby, Todd...
JACC: Basic to Translational Science. 1 (2016) 5 - p. 386-398 , 2016

Link: https://doi.org/10.1016/..

15

The TRAIL receptor agonist drozitumab targets basal B tripl..:

Dine, Jennifer L. ; O'Sullivan, Ciara C. ; Voeller, Donna...
Breast Cancer Research and Treatment. 155 (2016) 2 - p. 235-251 , 2016

Link: https://doi.org/10.1007/..